Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Type 1 Diabetes (T1D): early-phase trial registry
14 of 18 indexed Type 1 Diabetes (T1D) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #953 of 28,707 conditions by registered trial count.
18 US clinical trials · 14 currently recruiting · #953 of 28,707 conditions by registered trial count
Type 1 Diabetes (T1D): 18 US clinical trials tracked, 14 recruiting.
Type 1 Diabetes (T1D) is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 2 of these trials.
Enrollment posture brief
Registry condition type-1-diabetes-t1d
OPEN 14 | RECR 78% | LATE 0 | EARLY 5 | RANK #953 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Carcinoma (78% recruiting · 9 trials)
Type 1 Diabetes (T1D) lists 14 open slots (78% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Type 1 Diabetes (T1D) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Type 1 Diabetes (T1D) is recruiting above its size-band peers.
14 of 18 indexed trials (77.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Type 1 Diabetes (T1D) trials is spread across many organizations.
University of Colorado, Denver accounts for 2 of 18 trials (11.1%). 15 distinct sponsors appear on at least one study for this condition label.
-
Most Type 1 Diabetes (T1D) trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 18 trials that report a genuine target (sentinel values excluded). 13 of those (72.2%) plan for fewer than 100 participants.
-
Type 1 Diabetes (T1D) research is mostly interventional.
15 interventional and 3 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
18 total, page 1 of 1
Twiist Postmarket Surveillance Study for Type 1 Diabetes
Deka Research and Development
NCT07356089
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
University of Colorado, Denver
NCT07011147
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
Children's National Research Institute
NCT06618027
Automated Insulin for Management of Intrapartum Glycemia
University of California, San Francisco
NCT06883344
Circadian Mechanisms, Glucose, and CV Risks in T1D
University of Illinois at Chicago
NCT06624046
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
The Cleveland Clinic
NCT06694558
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Yale University
NCT06967701
Type 1 Diabetes REst for Metabolic Health
University of Colorado, Denver
NCT06627504
Type 1 Diabetes and Obstructive Sleep Apnea
University of Chicago
NCT06915831
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
University of Virginia
NCT07186660
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
GentiBio
NCT06919354
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
University Hospitals Cleveland Medical Center
NCT07154251
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Otsuka Pharmaceutical Factory
NCT06575426
Digital Mindfulness for Young Adults With Type 1 Diabetes
Yale University
NCT07062887
Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support
University of Pittsburgh
NCT06626347
Lactobacillus Johnsonii Supplementation in Adults With T1D
University of Florida
NCT03961347
Extended Follow-Up After Islet Transplantation in T1D
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01369082
Lactobacillus Johnsonii in Children and Adolescents With T1D
University of Florida
NCT03961854
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Type 1 Diabetes (T1D) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Type 1 Diabetes (T1D) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Type 1 Diabetes (T1D) page
18 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Type 1 Diabetes (T1D) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Colorado, Denver sponsors the most Type 1 Diabetes (T1D) trials on record, review their full trial history before evaluating a specific study. See University of Colorado, Denver's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Type 1 Diabetes (T1D) condition card totals 18 registered trials; most-linked intervention Placebo Capsule; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.